Strength and course of the SARS CoV-specific immune response after infection

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023047

Enrollment

Registered

2020-09-14

Start date

2020-09-09

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1

Interventions

Group 1: No intervention. The participants will be observed for 10-12 months. Blood samples will be taken 6, 9 and 12 months after infection.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adults with previous SARS CoV-2 infection

Exclusion criteria

Exclusion criteria: Pregnancy

Design outcomes

Primary

Measure	Time frame
The study measures the immune response to SARS CoV-2	—

Secondary

Measure	Time frame
No endpoint	—

Countries

Germany

Contacts

Public ContactChristian Jassoy

Institut für Medizinische Mikrobiologie und Virologie

christian.jassoy@medizin.uni-leipzig.de0341 9714314

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026